CLINICAL_TRIALS ClinicalTrials.gov record update

Open-label Phase II Trial to Evaluate Anti-tumor Activity and Safety of CLDN6 CAR-T ± CLDN6 RNA-LPX in Male Participants With Relapsed or Refractory Claudin 6-positive Testicular or Extragonadal Germ Cell Tumors

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT06940804
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:27:38.476710+00:00
Published At: 2025-07-02T00:00:00+00:00
Record Updated At: 2025-07-02
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Testicular Germ Cell Tumor", "Extragonadal Germ Cell Tumor"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-07-02"
protocolSection.identificationModule.nctId: "NCT06940804"
protocolSection.identificationModule.officialTitle: "Open-label Phase II Trial to Evaluate Anti-tumor Activity and Safety of CLDN6 CAR-T \u00b1 CLDN6 RNA-LPX in Male Participants With Relapsed or Refractory Claudin 6-positive Testicular or Extragonadal Germ Cell Tumors"
protocolSection.statusModule.overallStatus: "WITHDRAWN"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.